Log in
Enquire now
‌

US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer

Patent 11298362 was granted and assigned to Eli Lilly and Company on April, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.